Importantly, a diversity of clinical presentations in Rett syndrome has not hindered the adoption of the MECP2 model, while the diversity of sCP presentations seems to have spurred a multitude of animal models, all with different goals—from modelling risk factors to modelling symptoms. This evidence concerns the gene MECP2 and atypical Rett syndrome.